Cargando…
Progress in Neoantigen Targeted Cancer Immunotherapies
Immunotherapies that harness the immune system to kill cancer cells have showed significant therapeutic efficacy in many human malignancies. A growing number of studies have highlighted the relevance of neoantigens in recognizing cancer cells by intrinsic T cells. Cancer neoantigens are a direct con...
Autores principales: | Han, Xue-Jiao, Ma, Xue-lei, Yang, Li, Wei, Yu-quan, Peng, Yong, Wei, Xia-wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406675/ https://www.ncbi.nlm.nih.gov/pubmed/32850843 http://dx.doi.org/10.3389/fcell.2020.00728 |
Ejemplares similares
-
Targeting alternative splicing in cancer immunotherapy
por: Han, Nan, et al.
Publicado: (2023) -
Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy
por: Luo, Kunpeng, et al.
Publicado: (2022) -
Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy
por: Li, Xin-yu, et al.
Publicado: (2022) -
CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More
por: Ou, Xuejin, et al.
Publicado: (2021) -
Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)